Most Recent
Silk’s cancellation fee not recoverable after vacated trial
A judge has declined to pass on a senior barrister’s $18,000 cancellation fee as part of an adverse costs order for a vacated trial, noting that such fees are not standard or common practice.
Mercedes-Benz can’t access chats with Labor senator in $650M dealer suit
Mercedes can't access communications between Australia's peak body for car dealers and a Labor senator to use in its defence of a $650 million lawsuit over its decision to move to a fixed-price agency model.
Mercedes bullied car dealers, called them ‘baby piglets’, court told
Officials at the Mercedes-Benz Australia head office referred to car dealers as “baby piglets” in internal communications and threatened and bullied the retailers, a trial court has been told in a $650 million lawsuit over the car maker's decision to move to a fixed-price agency model.
Mercedes Benz CEO to hand over docs after dealers decry ‘unsatisfactory’ production
Mercedes Benz Australia will produce 10,000 pages of documentary evidence alongside material from CEO Florian Seidler, in its fight against a $650 million lawsuit brought by Australian dealers over the car maker’s decision to move to a fixed-price agency model.
Ex-Deloitte director accused of $3M fraud suspended from restructuring group
A former Deloitte director accused of embezzling $3.1 million to fund lavish purchases, including an extensive art collection, has been referred to police and suspended by an association for Australian restructuring professionals.
Deloitte director ordered to repay $3M in case of ‘remarkable fraud’
A former Deloitte director accused of embezzling $3.1 million has agreed to court orders that he repay the money and hand over title to all assets -- including almost 100 works of art -- purchased with the alleged misappropriated funds.
Mercedes-Benz dealers lose ‘ambitious’ bid to view confidential head office docs
Australian Mercedes-Benz dealers behind a $650 million lawsuit over the car maker’s decision to move to a fixed-price agency model have lost a bid for an “ambitious number” of dealers to view “super confidential” documents from the company’s head office in Germany.
Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.
Novartis challenges loss of experts in spat with Pharmacor over generic Gilenya
Novartis wants to appeal a ruling in its dispute with generic drug maker Pharmacor over patents for its multiple sclerosis drug Gilenya that tossed three of its four experts out of an upcoming so-called hot tub.
Independent candidate Zoe Daniel wins fight against council over yard signs
In a victory for Victorian independent candidate Zoe Daniel, the state's Supreme Court has found that promotional signs displayed on lawns did not fall foul of a local council ban on unauthorised displays.